This is a new experiment using AI agents to perform data analysis and create articles. Please understand that there may be ...

Acadia's latest trial update has put the spotlight on remlifanserin's development path, prompting analysts to reassess its ...

Acadia Pharmaceuticals' (ACAD) favorable risk-reward remains intact despite remlifanserin narrowly missing statistical significance in a phase 2 trial in Alzheimer's disease psych ...

Acadia stock tumbled Thursday after the company's experimental Alzheimer's disease psychosis treatment missed the mark.

I am not optimistic about remlifanserin’s phase 3 success, with a probability of success to 25% due to efficacy and trial ...

Acadia Pharmaceuticals announced topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating Remlifanserin in patients with Alzheimer's disea ...

Rogue AI agents hacked a government website, raising security concerns. OpenAI's valuation hitting $2.5T by December at 4.7% YES.

New Delhi The effort by BRICS countries effort to find common ground on international taxation is significant at a time when tax-related rules are being renegotiated around the world, finance minister ...

Objective To investigate the risk of incident cognitive disorders in patients with primary Sjögren’s disease (pSjD) using nationwide Korean National Health Insurance Service data.Methods This ...

Sitharaman said BRICS economies, as source jurisdictions and large developing economies that have built significant domestic ...

Rapport Therapeutics' current valuation reflects substantial optimism ahead of pivotal bipolar mania data for RAP-219. See why I rate RAPP stock a Hold.

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.